This inventor holds 1 USPTO granted patent. Top assignee: Biomay Ag. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Margit Focke: Innovator in Hypoallergenic Antigen Development
Introduction
Margit Focke is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of allergen research, particularly in the development of hypoallergenic mosaic antigens. Her innovative approach has the potential to improve the safety and efficacy of allergy treatments.
Latest Patents
Margit Focke holds a patent for a process titled "Process for the preparation of hypoallergenic mosaic antigens." This patent describes a method for creating hypoallergenic mosaic antigens derived from allergens. The process involves splitting the allergen into at least two parts and determining the IgE reactivity of each part. Subsequently, the parts that do not exhibit detectable IgE reactions are combined to form a mosaic antigen. This mosaic antigen retains the amino acids of the original allergen but alters their order, differentiating it from the naturally occurring allergen.
Career Highlights
Margit Focke is associated with Biomay AG, a company that focuses on biopharmaceuticals and innovative solutions in the field of allergy treatment. Her work at Biomay AG has been instrumental in advancing research and development in hypoallergenic products.
Collaborations
Margit collaborates with talented colleagues, including Nadine Mothes and Sabine Stumvoll. Their teamwork fosters a creative environment that enhances the development of innovative solutions in allergen research.
Conclusion
Margit Focke's contributions to hypoallergenic antigen development exemplify her dedication to improving allergy treatments. Her innovative patent and collaborative efforts at Biomay AG highlight her role as a leading inventor in this important field.